Update shared on20 Sep 2025
Fair value Decreased 80%Despite no material change in either future P/E or net profit margin, the consensus analyst price target for Zydus Wellness has sharply decreased from ₹2447 to ₹489.43.
What's in the News
- Incorporated wholly owned subsidiary Alidac UK Limited in the United Kingdom.
- Declared a dividend of INR 6 per equity share for FY25.
- Approved alteration of Capital Clause in Memorandum of Association at AGM.
- Held board meetings on June 17 and July 30 to discuss financial results.
Valuation Changes
Summary of Valuation Changes for Zydus Wellness
- The Consensus Analyst Price Target has significantly fallen from ₹2447 to ₹489.43.
- The Future P/E for Zydus Wellness remained effectively unchanged, moving only marginally from 36.76x to 36.88x.
- The Net Profit Margin for Zydus Wellness remained effectively unchanged, at 16.44%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.